TANGO THERAPEUTICS INC (TNGX:NASDAQ)
$28.56 0.92 (3.3285%)
Analysed TANGO THERAPEUTICS INC (TNGX:NASDAQ) News Sources
Tango Therapeutics Announces Pricing of $600 Million Upsized Public Offering
10-06-2026
yahoo.com
Is Tango Therapeutics (TNGX) Price Justified After Its 7x Surge In One Year
10-06-2026
yahoo.com
Daraxonrasib’s Phase 3 Pancreatic Cancer Survival Data Might Change The Case For Investing In RVMD
12-06-2026
yahoo.com
Tango Therapeutics Appoints Robert Azelby to Board of Directors
22-06-2026
yahoo.com
This Biotech ETF Has Almost Doubled in 13 Months. Money Is Flowing In.
26-06-2026
yahoo.com
TNGX Stock Outlook Hinges on Vopimetostat and Key 2026 Catalysts
02-07-2026
yahoo.com
Is TNGX Stock Still Worth Buying After Its Huge Rally in 2026?
02-07-2026
yahoo.com
Tango Therapeutics Rides a New Precision Oncology Trend in 2026
02-07-2026
yahoo.com
2 Monster Growth Stocks Analysts Think Can Reach New Highs
09-07-2026
yahoo.com
Tango Therapeutics (TNGX) to Benefit From Vopimetostat + KRAS Inhibitors Combined Revenues
15-07-2026
yahoo.com
What is the current price of TANGO THERAPEUTICS INC (TNGX:NASDAQ)?
The current price of TANGO THERAPEUTICS INC (TNGX:NASDAQ) is $28.56.
TANGO THERAPEUTICS INC (TNGX:NASDAQ) absolute price change since previous trading day?
The absolute price change of TANGO THERAPEUTICS INC (TNGX:NASDAQ) since the previous trading day is $0.92.
TANGO THERAPEUTICS INC (TNGX:NASDAQ) percentage price change since previous trading day?
The percentage price change of TANGO THERAPEUTICS INC (TNGX:NASDAQ) since the previous trading day is 3.3285%.
What is the most recent average sentiment score for TANGO THERAPEUTICS INC (TNGX:NASDAQ)?
The most recent average sentiment score for TANGO THERAPEUTICS INC (TNGX:NASDAQ) is 86 out of 100.
What is the most recent average sentiment for TANGO THERAPEUTICS INC (TNGX:NASDAQ)?
The most recent sentiment for TANGO THERAPEUTICS INC (TNGX:NASDAQ) is .
SEC-8K** Filing Available For TANGO THERAPEUTICS INC (TNGX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.